
Health Canada Approves Supplement with Immune-Health Epicor Ingredient
Products containing 500 mg of Epicor can now bear this claim in the Canadian market: “Helps reduce incidence of cold and flu symptoms.”
Health Canada has approved for sale in the Canadian market a natural health product containing immune-health ingredient
Additionally, EpiCor was given an approved health claim. Products containing 500 mg of Epicor can now bear this claim in the Canadian market: “Helps reduce incidence of cold and flu symptoms.”
Embria says EpciCor offers clear benefits without safety concerns caused by other ingredients currently available. “We believe that the cold and flu market in Canada needed something new and innovative, and EpiCor delivers that with very few warnings and cautions that are found on other products,” says Alex Azoulay, president of contract manufacturer
“This is a significant accomplishment for EpiCor since Health Canada’s process for confirming health claims is perhaps one of the most comprehensive in the world,” adds Paul Faganel, Embria’s president. “Recently, we’ve seen other immune products have issues with U.S. regulators, and we are very pleased Health Canada confirmed EpiCor’s research is second to none by allowing the Praxis product to use such strong claims.”
EpiCor also has a new dietary supplements (NDI) on file with FDA in the United States.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





